{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:01:02Z","timestamp":1793361662437,"version":"4.5.0"},"posted":{"date-parts":[[2024,9,24]]},"group-title":"Cancer Biology","reference-count":55,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T00:00:00Z","timestamp":1727136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,10,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  Liver disease, including hepatocellular carcinoma (HCC), is a major global health concern, claiming approximately 2 million lives worldwide annually, yet curative treatments remain elusive. In this study, we aimed to investigate the role of microRNA-21-5p (miR-21) in metabolic dysfunction-associated steatotic liver disease (previously NAFLD), metabolic-associated steatohepatitis (previously NASH), and HCC within the context of a Western high-fat diet, without additional choline (HFD) and offering potential therapeutic insights. We found that reduced miR-21 levels correlated with liver disease progression in WT mice fed on HFD, while miR-21 knockout mice showed exacerbated metabolic dysfunction, including obesity, hepatomegaly, hyperglycemia, insulin resistance, steatosis, fibrosis, and HCC. Our study reveals that miR-21 plays a protective role in metabolic syndrome and in the progression of liver disease to cancer. MiR-21 directly targets\n                  <jats:italic>Transforming growth factor beta-induced<\/jats:italic>\n                  (\n                  <jats:italic>Tgfbi<\/jats:italic>\n                  ), a gene also known to be significantly upregulated and a potential oncogene in HCC. Further, our study showed that intervention with the administration of a miR-21 mimic in WT livers effectively improves insulin sensitivity, steatosis, fibrosis,\n                  <jats:italic>Tgfbi<\/jats:italic>\n                  expression and tumor burden in HFD conditions. These findings indicate that miR-21 could serve as an effective strategy to delay or prevent liver disease in high-fat-diet environments.\n                <\/jats:p>\n                <jats:sec>\n                  <jats:title>Significance<\/jats:title>\n                  <jats:p>Our study demonstrates in vivo that miR-21 has protective functions in the broad spectrum of high-fat diet-based, progressive liver disease and cancer, and we show potential therapeutic value of a microRNA-21 mimic.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Graphical abstract<\/jats:title>\n                  <jats:fig id=\"ufig1\" position=\"float\" orientation=\"portrait\" fig-type=\"figure\">\n                    <jats:graphic xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"613915v2_ufig1\" position=\"float\" orientation=\"portrait\"\/>\n                  <\/jats:fig>\n                <\/jats:sec>","DOI":"10.1101\/2024.09.19.613915","type":"posted-content","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T11:20:14Z","timestamp":1727176814000},"source":"Crossref","is-referenced-by-count":3,"title":["miR-21: A therapeutic target for delaying severe liver disease and hepatocellular carcinoma in high-fat-diet-fed mice"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2438-7003","authenticated-orcid":false,"given":"Urmila","family":"Jagtap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anan","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuho","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylie A.","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergei","family":"Manakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyongyi","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imad","family":"Nasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8263-0409","authenticated-orcid":false,"given":"Frank J.","family":"Slack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"issue":"8","key":"2024100904401858000_2024.09.19.613915v2.1","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.cgh.2023.04.015","article-title":"The Global Burden of Liver Disease","volume":"21","year":"2023","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"2024100904401858000_2024.09.19.613915v2.2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21763"},{"key":"2024100904401858000_2024.09.19.613915v2.3","doi-asserted-by":"crossref","unstructured":"Rinella ME , Lazarus J V , Ratziu V , Francque SM , Sanyal AJ , Kanwal F , et al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023 Jun 24;","DOI":"10.1097\/HEP.0000000000000696"},{"key":"2024100904401858000_2024.09.19.613915v2.4","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29367"},{"issue":"3","key":"2024100904401858000_2024.09.19.613915v2.5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-021-00565-8","article-title":"Natural history of NAFLD: knowns and unknowns","volume":"19","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"8","key":"2024100904401858000_2024.09.19.613915v2.6","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1053\/j.gastro.2016.01.037","article-title":"Genetic Factors That Affect Risk of Alcoholic and Nonalcoholic Fatty Liver Disease","volume":"150","year":"2016","journal-title":"Gastroenterology"},{"key":"2024100904401858000_2024.09.19.613915v2.7","doi-asserted-by":"crossref","unstructured":"Chen Y , Wang W , Morgan MP , Robson T , Annett S . Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets. Front Endocrinol (Lausanne). 2023;14:1148934.","DOI":"10.3389\/fendo.2023.1148934"},{"issue":"2","key":"2024100904401858000_2024.09.19.613915v2.8","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jcmgh.2018.10.016","article-title":"Resolving the Paradox of Hepatic Insulin Resistance","volume":"7","year":"2019","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"6","key":"2024100904401858000_2024.09.19.613915v2.9","first-page":"536","article-title":"Obesity and the Western Diet: How We Got Here","volume":"117","year":"2020","journal-title":"Mo Med"},{"key":"2024100904401858000_2024.09.19.613915v2.10","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-016-0477-5"},{"key":"2024100904401858000_2024.09.19.613915v2.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2020.109199"},{"key":"2024100904401858000_2024.09.19.613915v2.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2015.12.012"},{"key":"2024100904401858000_2024.09.19.613915v2.13","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-015-4002-4"},{"key":"2024100904401858000_2024.09.19.613915v2.14","doi-asserted-by":"publisher","DOI":"10.4161\/rna.8.5.16154"},{"key":"2024100904401858000_2024.09.19.613915v2.15","doi-asserted-by":"crossref","unstructured":"Zhang T , Yang Z , Kusumanchi P , Han S , Liangpunsakul S . Critical Role of microRNA-21 in the Pathogenesis of Liver Diseases. Front Med (Lausanne). 2020;7:7.","DOI":"10.3389\/fmed.2020.00007"},{"key":"2024100904401858000_2024.09.19.613915v2.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2013.05.021"},{"key":"2024100904401858000_2024.09.19.613915v2.17","doi-asserted-by":"publisher","DOI":"10.2217\/bmm-2018-0096"},{"key":"2024100904401858000_2024.09.19.613915v2.18","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2015.2076"},{"key":"2024100904401858000_2024.09.19.613915v2.19","doi-asserted-by":"publisher","DOI":"10.2217\/bmm-2018-0096"},{"key":"2024100904401858000_2024.09.19.613915v2.20","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2001039"},{"key":"2024100904401858000_2024.09.19.613915v2.21","doi-asserted-by":"crossref","unstructured":"Sheedy FJ . Turning 21: Induction of miR-21 as a Key Switch in the Inflammatory Response. Front Immunol. 2015 Jan 29;6.","DOI":"10.3389\/fimmu.2015.00019"},{"issue":"4","key":"2024100904401858000_2024.09.19.613915v2.22","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3892\/br.2016.747","article-title":"Emerging role of microRNA-21 in cancer","volume":"5","year":"2016","journal-title":"Biomed Rep"},{"issue":"10","key":"2024100904401858000_2024.09.19.613915v2.23","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1111\/liv.15682","article-title":"miR-21-5p promotes NASH-related hepatocarcinogenesis","volume":"43","year":"2023","journal-title":"Liver Int"},{"key":"2024100904401858000_2024.09.19.613915v2.24","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-308430"},{"key":"2024100904401858000_2024.09.19.613915v2.25","doi-asserted-by":"publisher","DOI":"10.3892\/or.2012.1682"},{"key":"2024100904401858000_2024.09.19.613915v2.26","doi-asserted-by":"crossref","unstructured":"Hochreuter MY , Dall M , Treebak JT , Barr\u00e8s R . MicroRNAs in non-alcoholic fatty liver disease: Progress and perspectives. Mol Metab. 2022 Nov;65:101581.","DOI":"10.1016\/j.molmet.2022.101581"},{"key":"2024100904401858000_2024.09.19.613915v2.27","doi-asserted-by":"crossref","unstructured":"Zhang X , Deng F , Zhang Y , Zhang X , Chen J , Jiang Y . PPAR\u03b3 attenuates hepatic inflammation and oxidative stress of non-alcoholic steatohepatitis via modulating the miR-21-5p\/SFRP5 pathway. Mol Med Rep. 2021 Nov;24(5).","DOI":"10.3892\/mmr.2021.12463"},{"issue":"4","key":"2024100904401858000_2024.09.19.613915v2.28","doi-asserted-by":"crossref","first-page":"e2748","DOI":"10.1038\/cddis.2017.172","article-title":"miR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in mice","volume":"8","year":"2017","journal-title":"Cell Death Dis"},{"key":"2024100904401858000_2024.09.19.613915v2.29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.toxlet.2016.06.012","article-title":"MicroRNA-21 is associated with fibrosis in a rat model of nonalcoholic steatohepatitis and serves as a plasma biomarker for fibrotic liver disease","volume":"258","year":"2016","journal-title":"Toxicol Lett"},{"key":"2024100904401858000_2024.09.19.613915v2.30","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-310822"},{"key":"2024100904401858000_2024.09.19.613915v2.31","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-308883"},{"key":"2024100904401858000_2024.09.19.613915v2.32","doi-asserted-by":"crossref","unstructured":"Zhang T , Yang Z , Kusumanchi P , Han S , Liangpunsakul S . Critical Role of microRNA-21 in the Pathogenesis of Liver Diseases. Front Med (Lausanne). 2020;7:7.","DOI":"10.3389\/fmed.2020.00007"},{"key":"2024100904401858000_2024.09.19.613915v2.33","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2015.2076"},{"key":"2024100904401858000_2024.09.19.613915v2.34","doi-asserted-by":"crossref","unstructured":"Correia de Sousa M , Calo N , Sobolewski C , Gjorgjieva M , Cl\u00e9ment S , Maeder C , et al. Mir-21 Suppression Promotes Mouse Hepatocarcinogenesis. Cancers (Basel). 2021 Oct 4;13(19).","DOI":"10.3390\/cancers13194983"},{"key":"2024100904401858000_2024.09.19.613915v2.35","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.omtn.2021.06.019","article-title":"miR-21 mimic blocks obesity in mice: A novel therapeutic option","volume":"26","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"issue":"27","key":"2024100904401858000_2024.09.19.613915v2.36","doi-asserted-by":"crossref","first-page":"44050","DOI":"10.18632\/oncotarget.17211","article-title":"Circulating miR-21 serves as a serum biomarker for hepatocellular carcinoma and correlated with distant metastasis","volume":"8","year":"2017","journal-title":"Oncotarget"},{"key":"2024100904401858000_2024.09.19.613915v2.37","doi-asserted-by":"publisher","DOI":"10.1002\/mc.21864"},{"issue":"6","key":"2024100904401858000_2024.09.19.613915v2.38","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41592-019-0422-y","article-title":"CancerMine: a literature-mined resource for drivers, oncogenes and tumor suppressors in cancer","volume":"16","year":"2019","journal-title":"Nat Methods"},{"key":"2024100904401858000_2024.09.19.613915v2.39","doi-asserted-by":"publisher","DOI":"10.1101\/2022.02.13.480296"},{"key":"2024100904401858000_2024.09.19.613915v2.40","doi-asserted-by":"crossref","unstructured":"Agarwal V , Bell GW , Nam JW , Bartel DP . Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015 Aug 12;4.","DOI":"10.7554\/eLife.05005"},{"key":"2024100904401858000_2024.09.19.613915v2.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgg.2021.07.007"},{"key":"2024100904401858000_2024.09.19.613915v2.42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms130810461"},{"key":"2024100904401858000_2024.09.19.613915v2.43","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkab970"},{"key":"2024100904401858000_2024.09.19.613915v2.44","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.05607"},{"issue":"1","key":"2024100904401858000_2024.09.19.613915v2.45","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cels.2017.12.006","article-title":"Integration of Multi-omics Data from Mouse Diversity Panel Highlights Mitochondrial Dysfunction in Non-alcoholic Fatty Liver Disease","volume":"6","year":"2018","journal-title":"Cell Syst"},{"key":"2024100904401858000_2024.09.19.613915v2.46","doi-asserted-by":"crossref","unstructured":"Benegiamo G , von Alvensleben GVG , Rodr\u00edguez-L\u00f3pez S , Goeminne LJE , Bachmann AM , Morel JD , et al. The genetic background shapes the susceptibility to mitochondrial dysfunction and NASH progression. J Exp Med. 2023 Apr 3;220(4).","DOI":"10.1084\/jem.20221738"},{"key":"2024100904401858000_2024.09.19.613915v2.47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0155163"},{"key":"2024100904401858000_2024.09.19.613915v2.48","first-page":"1160053","article-title":"An update on animal models of liver fibrosis","volume":"10","year":"2023","journal-title":"Front Med (Lausanne"},{"key":"2024100904401858000_2024.09.19.613915v2.49","doi-asserted-by":"publisher","DOI":"10.1111\/j.0959-9673.2006.00465.x"},{"key":"2024100904401858000_2024.09.19.613915v2.50","doi-asserted-by":"publisher","DOI":"10.1177\/0023677215570078"},{"key":"2024100904401858000_2024.09.19.613915v2.51","doi-asserted-by":"crossref","unstructured":"Chen Y , Zhao H , Feng Y , Ye Q , Hu J , Guo Y , et al. Pan-Cancer Analysis of the Associations of TGFBI Expression With Prognosis and Immune Characteristics. Front Mol Biosci. 2021;8:745649.","DOI":"10.3389\/fmolb.2021.745649"},{"key":"2024100904401858000_2024.09.19.613915v2.52","doi-asserted-by":"crossref","unstructured":"Han B , Cai H , Chen Y , Hu B , Luo H , Wu Y , et al. The role of TGFBI (\u03b2ig-H3) in gastrointestinal tract tumorigenesis. Mol Cancer. 2015 Mar 24;14:64.","DOI":"10.1186\/s12943-015-0335-z"},{"issue":"3","key":"2024100904401858000_2024.09.19.613915v2.53","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/s12276-023-00947-9","article-title":"TGFBI remodels adipose metabolism by regulating the Notch-1 signaling pathway","volume":"55","year":"2023","journal-title":"Exp Mol Med"},{"key":"2024100904401858000_2024.09.19.613915v2.54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115922"},{"key":"2024100904401858000_2024.09.19.613915v2.55","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20701"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2024.09.19.613915","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T07:07:03Z","timestamp":1768460823000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2024.09.19.613915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,24]]},"references-count":55,"URL":"https:\/\/doi.org\/10.1101\/2024.09.19.613915","relation":{},"subject":[],"published":{"date-parts":[[2024,9,24]]},"subtype":"preprint"}}